|
Italy-MB-MB Azienda Directories
|
Azienda News:
- Lincomycin hydrochloride and Dexamethasone drug interactions - a phase . . .
Summary: The phase IV clinical study analyzes what interactions people have when they take Lincomycin hydrochloride and Dexamethasone It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly
- Medicines to avoid if you have ADPKD - PKD) Charity
This webpage is for people with autosomal dominant polycystic kidney disease (ADPKD), their families, friends and carers It explains which medicines you may need to avoid if you have ADPKD
- Diclofenac (oral route) - Side effects dosage - Mayo Clinic
Some side effects may occur that usually do not need medical attention These side effects may go away during treatment as your body adjusts to the medicine Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects
- Medications to Avoid in Patients With Polycystic Kidney Disease
Nearly half of all medications are cleared by the kidneys This has implications for patients with polycystic kidney disease (PKD) and requires careful attention to medication usage
- Lincocin (lincomycin) dosing, indications, interactions, adverse . . .
Medscape - Indication-specific dosing for Lincocin (lincomycin), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy lactation schedules, and cost
- Drug Interactions Checker - Check Your Brand and Generic Drugs - RxList
The interaction may increase or decrease the effectiveness of the drugs or the side effects of the drugs The likelihood of drug interactions increases as the number of drugs being taken increases
- Lincomycin: Uses, Interactions, Mechanism of Action | DrugBank
Lincomycin is indicated for the treatment of serious bacterial infections by susceptible strains of streptococci, pneumococci, and staphylococci in patients who are allergic to penicillins or for situations in which a penicillin is deemed inappropriate
- Metabolically inert antifolates for treating disorders of abnormal . . .
U S Patent Application 20060111272 for Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation
- 136192_NDH12 - The Point
compatible for at least 30 minutes provisionally compatible; give within 15 minutes provisionally compatible; give within 5 minutes not compatible conflicting data (A blank space indicates no available data )
|
|